Treatments administering chimeric IgG Fc receptor comprising an extracellular domain of CD64
Assignee
Regents of the University of Minnesota
Inventors
Jianming Wu, Bruce Kenneth Walcheck, Robert Harrison Hullsiek, Yungfang Li, Hemant Kumar Mishra
Abstract
A recombinant immune cell expresses a heterologous IgG Fc receptor. In some embodiments, the heterologous IgG Fc receptor can be a chimeric IgG Fc receptor. Generally, the chimeric IgG Fc receptor includes an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain generally includes a sufficient portion of CD64 to bind to an IgG Fc region. The intracellular domain of the chimeric IgG Fc receptor includes a sufficient portion of an Fc receptor allowing immunoreceptor tyrosine-based activation motif (ITAM) to initiate cell signaling when an IgG Fc region binds to the extracellular domain.
CPC Classifications
Filing Date
2023-09-26
Application No.
18474781
Claims
9